The Skin Genetics Research Group operates within a multidisciplinary clinical–academic environment, with access to a range of resources that support its research activities in inherited and acquired skin disorders.

Imaging and Phenotyping Tools

Dermoscopy is used routinely to achieve detailed phenotypic characterization of skin disorders. This tool enables precise clinicopathological correlation and supports genotype–phenotype analyses, enhancing the group's translational and personalized dermatology research.

Skin Biopsy and Dermatopathology Facilities

The group is supported by dedicated dermatopathology facilities that enable detailed histological analysis of skin biopsy specimens. These resources support accurate clinicopathological correlation and provide essential insights into the morphological features of inherited and acquired skin disorders, forming a core component of the group's clinical and translational research.

Molecular Diagnostics and Next-Generation Sequencing (NGS)

Advanced molecular diagnostic platforms support targeted molecular testing and next-generation sequencing (NGS). These technologies enable comprehensive genetic analysis, mutation detection, and variant characterization, underpinning research into the molecular mechanisms of skin disease and facilitating genotype–phenotype correlation.

Immunofluorescence

Immunofluorescence techniques are used to detect and localize specific proteins, antibodies, or antigens in skin tissue. This approach provides critical insights into disease mechanisms, supports diagnostic confirmation of autoimmune or inflammatory skin disorders, and complements molecular and phenotypic analyses conducted by the group.​

Research Funding

The group's research activities are supported through competitive funding, primarily provided by The Jordan University. These funds enable access to laboratory equipment, molecular diagnostics, and specialized software, supporting both high-quality translational studies and collaborative projects.​

Collaborative Data Resources

The group maintains a partnership with the Jordanian Cancer Registry, providing access to comprehensive, high-quality clinical and genetic data. This collaboration enables population-level analyses, supports genotype–phenotype correlation studies, and strengthens the group's capacity to conduct impactful research in dermatology and oncology.